Alphapuppy - ASM Questions for David Innes, Linda Powers, Les Goldman, Marnix Bosch, Kevin Duffy, Jean Davis, BoD and SAB.
________________________________________________________________________
Hi Alpha,
Below is a previous post of questions I have for the ASM meeting as I see them kicking the can, yet again. The proxy will be a request for another shelf offering so they can further dilute the stock and live off their mismanagement. Any timelines provided are worthless as they have shown a vast propensity to not know how to adhere to one.
I have decided to go to the ASM so I can watch them lie to me in person.
They do not know how to be honest with their community of patients and investors. They are just good at talking out the side of their mouths and dangling the preverbal carrot.
I have pretty much written this invest off because of the mismanagement from the leadership not the hard work of Linda Liau and the researchers.
If this ASM doesn't go well I see .05 SP and lawsuits to waste any funds they get from further dilution.
________________________________________________________________________
I have been following the IHUB MB for a few years looking for nuggets of gold amongst the noise and gauging the temperature of other long-term investors and those that appear to be pumpers or shorts. I have been invested in NWBO since early 2014 and I am considering going to the ASM to asks some very pointed questions to the Company Management, Board of Directors and Scientific Advisory Board. This comes from frustration as an investor and seeing friends pass from GBM, other cancers that DCVax-L or Direct could have helped prolong their lives and/or give them a better quality of life through the treatment – it has truly been sad to see.
Are you going to ASM? Have questions you want to have addressed?
Either way - what are some questions you would like to hear the NWBO team address?
Let’s define the NWBO team as the following –
Company Management (CM) – Linda, Les, Alton, Marnix, Anthony, David,
Kevin, and Jean
Board of Directors (BoD) – Linda, Alton, Navid, Jerry, Cofer
Scientific Advisory Board (SAB) – Dr. Mac Cheever, Dr. Alfredo
Quinones-Hinojosa, Dr. Jerome Galon,
Dr. Samir N. Khleif, Dr. John Smyth
It would be great to get a list of questions compiled for them to address at the ASM meeting for the potential patients and frustrated longs. Is it too much to ask to provide a straight answer - not legal ease, posturing, words that are leading to speculation or open-ended? A real status, with a timeline for the next steps. At this point, with there being little to no trust in the long-term company management and David, maybe see the new blood Kevin and Jean get involved to provide some details vs the malarkey we have dealt with for years.
Yes, I know there are the AF's, CT's and some other rogue actors out there but Cofer is supposed to be watching all that and dealing with it in the future and we are already pretty much at zero financially so what is there to lose with some straight talk and transparency with investors.
Please chime in with your questions and let’s leave all speculation out of the thread to make it easier for David Innes to follow (we all know he reads this board). We do not need any more infomercials – we need some transparency to rebuild trust or new board of directors that will hold a new management team accountable. I’ll start with some below –
1) Specifically, address what activities have taken place since November 2018 with a timeline so we can see there is forward momentum and build up trust with your community (Doctors, Patients, and Investors)?
2) What steps, in order, are remaining to gain approval in each of the four RA’s with a timeline and what can be occurring simultaneously?
3) What activities are being undertaken to stop the dilution of share price to drive shareholder value and save/prolong people’s lives with minimal side effects?
4) If we continue to move forward at the current pace when will the current team step aside for leadership that knows how to get this to completion?
5) When will the company start doing arm’s length transactions?
6) Why will NWBO not partner with others to stop the dilution and get a product through the pipeline to patients?
7) Why does the company not focus on getting a single task completed vs spending time/energy/funds on other activities that are announced and never heard about again; thus creating false hope for the community and more broken trust. Items such as colorectal cancer with Merck and the UoMainz, DCVax Direct Phase next phase, Drug trails with Merck product, etc. These things just frustrate people and are a tease to both potential patients and investors alike generating many useless cycles of energy expended.
Please add your questions…..
8) ….
9) …….
10) ……….
11) Etcetera
I have a feeling if positive news is not announced prior to and/or at the meeting and if they are requesting an increase in shares, that this will be an interesting meeting for the management, not the investors or potential patients. It is time, we (longs and the angel investors) hold them all accountable (CM, BoD, SAB) and stop the slow drip insanity. Maybe NWBO’s insolvency will allow UCLA and Linda Liau to provide the license and technology to someone that will be successful in getting a new cancer platform to market.
I hope the answer to Question 1 above reflects they have been diligent and working smart the past 17 months (11/2018 – 4/2020), have unblinded, are completing preparation for TLD in "XX" days for the SAP and can provide a specific near-term week the four RA’s will receive the accelerated approval request.
Looking forward to seeing what all questions you longs have in mind and how many are going to ASM. Let's load this up over the weekend so David has some nice reading material Monday morning.
All the best and have a great weekend!
Gloom, Despair, and Agony!!!
AI
